Thanks, Andy and good morning, everyone. Let's turn to Slide 4 for a review of our consolidated financial results. In the first quarter, sales were $90.5 million, up 8.9% year-over-year on solid end market demand. Adjusted EBITDA rose 9.7% to $11.3 million, delivering a 12.5% margin. We generated $5.1 million of cash from operations, a $1.5 million increase and maintained a low net debt of $41.9 million. On the right, our sales bridge shows that volume and mix contributed $7.2 million driven by off-cycle defense pull-ins for MREs and flares, plus an improving aerospace backlog. Pricing added $0.5 million, reflecting SCBA escalators and selected customer increases partially offset by repricing in Elektron due to certain lower input costs. FX was a modest $0.3 million headwind. For our adjusted EBITDA walk, net deflation added $0.6 million. Volume and mix and pricing contributed $3.7 million and $0.5 million, respectively, while adverse factors of $3.7 million largely reflect $1.7 million of transitional production costs and $1.2 million of elevated logistics and ongoing investments. For a full breakdown, please see the detailed waterfall in the appendix on Slide 12. Now let's turn to Slide 5 for a detailed review of Elektron's first quarter financial performance. Our Elektron segment harnesses proprietary magnesium and zirconium platforms in markets where higher performance is critical. We serve customers who demand deep technical expertise, whether that's ultra lightweight alloys that extend aircraft range and cut fuel burn, countermeasure flares and self-heating MRE powders that protect and sustain personnel in extreme conditions or zirconium-based catalysts and oxides that drive precision in advanced manufacturing, clean energy solutions and critical health care applications. By focusing on high barrier defense and aerospace driven end markets, Elektron commands premium pricing and high margins, powering sustained growth as global demand for safety, reliability and performance continues to climb. In the first quarter, Elektron sales rose to $49.4 million, up 31% from $37.7 million a year ago. Adjusted EBITDA increased to $8.7 million and our EBITDA margin expanded to 17.6%, 120 basis points improvement versus the prior year. Growth was broad-based across our core end markets. Defense, First Response and Healthcare led the way, up 76%. Customers continue to restock flameless ration heaters and Meals Ready-to-Eat products and demand for our related UGR-E product is still increasing. We also saw a meaningful pickup of demand for both our magnesium aerospace alloys and magnesium powders for countermeasure flares as customer manning and production issues began to ease across both market sectors. Alloys lifted our transportation revenues by approximately 11% despite some softness in automotive catalysis. In Specialty Industrial, market conditions resulted in flat to modest growth of around 1%. Adjusted EBITDA margin expansion reflects the impact of higher volumes relative to fixed costs, as well as a favorable shift towards higher-value defense programs. Furthermore, there is ongoing payoff from the site consolidation and lean operational efficiencies we embedded under our Luxfer Business System last year, which will continue to deliver cost savings and margin resilience. Overall, Luxfer's performance underscores the power of focused execution and targeted innovation. With that, let's turn to Slide 6 for our Gas Cylinders results. Luxfer Gas Cylinders is the benchmark for mission-critical pressure vessels anchored by SCBA market leadership and long-standing partnership with blue-chip OEMs. Our lightweight rugged cylinders protect fire emergency and hazardous environment teams while our high-performance, high-strength cylinders enable life support and operations in aerospace and space exploration applications. We also serve specialty industrial, medical and alternative fuel markets with precision engineered solutions. Backed by proprietary processes and rigorous qualifications, this segment commands premium pricing and delivers resilient margins in high barrier markets. In the first quarter, Gas Cylinders revenue was $41.1 million, down 9% from $45.4 million in quarter 1, 2024 and adjusted EBITDA came in at $2.6 million, reflecting a 6.3% margin versus 9% last year. This performance was largely in line with our expectations. We saw softer demand in alternative fuel cylinders with the heavy-duty truck market still subdued. Aerospace and especially space exploration demand is robust, although overall transportation sales declined about 23% year-over-year. However, despite the anticipated softness in alternative fuels, the strong aerospace volumes and the order for our first bulk gas transportation module will open new opportunities for future growth. Although down 7%, our Defense, First Response and Healthcare business held up relatively well with steady orders for SCBA and an improving outlook. Specialty Industrial posted a notable 25% increase driven by electronic and calibration gas applications. Margin compression resulted from the lower volumes, although pricing actions helped offset some headwinds. Importantly, the efficiency initiatives we put in place last year are now starting to stabilize margins and we expect these permanent measures to support stronger second half. In summary, while gas cylinders face headwinds in certain end markets, our core first responder, aerospace and health care-related cylinders remained resilient and our cost and efficiency focus will continue to drive improvements. Now please turn to Slide 7 for an update on our full year 2025 financial guidance. I'd like to reinforce 2 key themes from Andy's opening comments. Our tariff resilience and the strength of our backlog across defense, first response and aerospace applications, combined with our diversified portfolio, these factors give us some confidence despite the uncertain macroeconomic outlook. Accordingly, we are reaffirming our full year 2025 guidance, unchanged from what we communicated in February with expectations for flat revenue growth. We continue to anticipate adjusted diluted earnings per share in the range of $0.95 to $1.05 and adjusted EBITDA between $48 million and $52 million and free cash flow generation of $20 million to $25 million for the full year. This outlook reflects our confidence in the aggregate underlying demand from our end markets combined with disciplined cost management, prudent price actions and tight working capital controls. That said, foreign exchange does remain a key sensitivity and indeed, we have seen significant volatility in the last few weeks. For our business, a $0.05 move in the dollar versus sterling can shift our full year earnings by around $1 million, although we continue to hedge selectively to mitigate some of that risk. On capital deployment, we will maintain our routine share repurchase program with board authorization for up to $10 million of additional opportunistic buybacks. We're also evaluating further simplification and cost reduction initiatives to drive improved efficiencies across our operations. We remain confident that our fortress balance sheet and diversified end market exposure will enable us to navigate any remaining headwinds and deliver on our projections. Now I'd like to pass the call back to Andy.